USC researchers are evaluating a blood test that detects tumor-associated extracellular vesicles and rare cancer cells, potentially improving early breast cancer detection alongside mammography...
Read More »The hidden risks of exosome treatments
Extracellular vesicles and exosomes are being explored for skin and hair treatments, but concerns remain about product quality, long-term safety, and lack of FDA approval...
Read More »Aegle Therapeutics announces first patient dosed in Phase 1/2a trial of AGLE-102™ comprised of extracellular vesicles isolated from allogeneic stem cells
AGLE-102 is a novel extracellular vesicle therapy being developed for the treatment of rare and immuno-dermatological disorders. Aegle Therapeutics, a...
Read More »Coya Therapeutics Secures $10 Million Financing to Advance Clinical and Pre-Clinical Pipeline of Treg-Derived Exosome Therapeutics
Coya Therapeutics, a clinical-stage biotechnology company developing multiple first-in-class and best-in-class approaches that enhance regulatory T cell (Treg) function, today announced that it has raised approximately $10.3 million from institutional and...
Read More »Medicare claws back money for dubious exosome treatments
The notice applies to amniotic, placental, and umbilical cord injectables, which the WPS notice describes as “experimental exosome biologic products that have not proven to be safe and effective for any medical use...”
Read More »FoundationOne Liquid CDx receives expanded FDA indication in Metastatic Castration-Resistant Prostate Cancer
Foundation Medicine, Inc. announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®Liquid CDx to be used as a companion diagnostic for...
Read More »A multianalyte panel consisting of extracellular vesicle miRNAs and mRNAs, cfDNA, and CA19-9 shows utility for diagnosis and staging of pancreatic ductal adenocarcinoma
University of Pennsylvania researchers analyzed plasma from 204 subjects (71 healthy, 44 non-PDAC pancreatic disease, and 89 PDAC) for the following biomarkers: tumor-associated extracellular vesicle miRNA and mRNA isolated on a nanomagnetic platform...
Read More »A new clinical study to evaluate the safety and tolerance of aerosol inhalation of MSC exosomes
Exosomes are naturally occurring nanosized vesicles and comprised of natural lipid bilayers with the abundance of adhesive proteins that readily...
Read More »Liquid Biopsy for Hematologic Neoplasms Receives Medicare Coverage
Genomic Testing Cooperative announced that the Medicare Administrative Contractor Palmetto GBA (MolDX®) has finalized its review and has established coverage for two Genomic Testing Cooperative (GTC) hematology profiles: GTC-Hematology...
Read More »Manufacturing Exosomes – A Promising Therapeutic Platform
Extracellular vesicles, in particular the subclass exosomes, are rapidly emerging as a novel therapeutic platform. However, currently very few clinical validation studies and no clearly defined manufacturing process exist. As exosomes progress towards the clinic for treatment of a vast ...
Read More »
Exosome RNA Exosome RNA Research & Industry News
